BioTelemetry (BEAT) Soars: Stock Up 22.0% - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

BioTelemetry, Inc. ( BEAT ) was a big mover last session, as its shares surged over 22% on the day. The surge came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the healthcare stock as it is now trading above the volatile price range of $6.88 to $8.74 in the past one-month time frame.

In the last 30 days, the company did not witness any estimate revision and its Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

BioTelemetry currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Charles River Laboratories International, Inc. ( CRL ), Covance Inc. ( CVD ) and Quintiles Transnational Holdings Inc. ( Q ). All three sport a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

BIOTELEMETRY (BEAT): Free Stock Analysis Report

CHARLES RVR LAB (CRL): Free Stock Analysis Report

COVANCE INC (CVD): Free Stock Analysis Report

QUINTILES TRANS (Q): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: BEAT , CRL , CVD , Q

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by